Lite Strategy LITS
NASDAQ LITS
$1.16 -0.03 (-2.52%)
At close: Oct 23, 2026 · 4:00 PM EDT

Lite Strategy (LITS) Cash & Current Investments (2010 - 2026)

Updated

Lite Strategy (LITS) recorded Cash & Current Investments of $5.71 million in fiscal Q4 2026 (quarter ended Jun 30, 2026), down 68.3% from $18 million a year earlier and down 24.4% from the prior quarter.

Analysis

Lite Strategy (LITS) Cash & Current Investments (2010 - 2026) Analysis & Trends

Starting with fiscal Q1 2011, Lite Strategy's Cash & Current Investments history includes 64 quarters.

  • Annual Cash & Current Investments has declined for six straight fiscal years, with a five-year compound annual growth rate of -48.2% (FY2021 to FY2026).
  • Across earlier fiscal years, Cash & Current Investments came in at $18 million in FY2025 (-53.0%), $38.3 million in FY2024 (-62.0%), $100.71 million in FY2023 (-34.3%) and $153.25 million in FY2022 (-0.1%).
  • The fiscal Q4 2026 figure is the lowest quarterly Cash & Current Investments since fiscal Q1 2013.
  • On a year-over-year basis, Cash & Current Investments has declined for 17 consecutive quarters, with an average decline of 62.6% over the last eight quarters.
  • Peak year-over-year performance for Cash & Current Investments in the last five years was growth of 3.1% in fiscal Q2 2022, against a decline of 68.3% in fiscal Q4 2026 at the low end.
  • Per Business Quant, the preceding three fiscal quarters came in at $7.54 million (Q3 2026), $8.76 million (Q2 2026) and $10.11 million (Q1 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 17.23 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 6.57 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 7.69 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 4.90 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 3.18 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 11.70 Bn
10 Lite Strategy 37.59 Mn 5.47 Mn - 5.71 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 5.71 Mn
Mar 31, 2026 7.54 Mn
Dec 31, 2025 8.76 Mn
Sep 30, 2025 10.11 Mn
Jun 30, 2025 18.00 Mn
Mar 31, 2025 20.50 Mn
Dec 31, 2024 23.70 Mn
Sep 30, 2024 26.90 Mn
Jun 30, 2024 38.30 Mn
Mar 31, 2024 56.60 Mn
Dec 31, 2023 59.50 Mn
Sep 30, 2023 82.20 Mn
Jun 30, 2023 100.71 Mn
Mar 31, 2023 112.04 Mn
Dec 31, 2022 124.17 Mn
Sep 30, 2022 138.37 Mn
Jun 30, 2022 153.25 Mn
Mar 31, 2022 169.04 Mn
Dec 31, 2021 185.75 Mn
Sep 30, 2021 145.50 Mn
API Access

Lite Strategy Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=LITS&period=max&api_key=YOUR_API_KEY